PeptideDB

Ovuplant

CAS No.: 70235-53-9

Ovuplant is for a short-term-release implant containing deslorelin acetate.
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description Ovuplant is for a short-term-release implant containing deslorelin acetate.
molecular weight 1339.5
Molecular formula C66H86N18O13
CAS 70235-53-9
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year
References 1. Finan SA, Lamkin EL, McKinnon AO. Comparative efficacy of BioRelease Deslorelin® injection for induction of ovulation in oestrus mares: a field study. Aust Vet J. 2016 Sep;94(9):338-40. doi: 10.1111/avj.12478. PubMed PMID: 27569838. 2. Wolf T, Meyer H, Kutzler M. Litter size response to oestrous induction with deslorelin (Ovuplant®) in dogs. Reprod Domest Anim. 2012 Dec;47 Suppl 6:387-8. doi: 10.1111/rda.12082. PubMed PMID: 23279545. 3. Fontaine C. Long-term contraception in a small implant: A review of Suprelorin (deslorelin) studies in cats. J Feline Med Surg. 2015 Sep;17(9):766-71. doi: 10.1177/1098612X15594990. Review. PubMed PMID: 26323800; PubMed Central PMCID: PMC5117121. 4. Hemberg E, Lundeheim N, Einarsson S. Successful timing of ovulation using deslorelin (Ovuplant) is labour-saving in mares aimed for single ai with frozen semen. Reprod Domest Anim. 2006 Dec;41(6):535-7. PubMed PMID: 17107513.